Menu
  • Anmelden
  • Suche

Allergologie select, Volume 7 (2023) - 1st issue (229 - 235)

DGAKI and PEI in dialogue 2023: Diagnostics and allergen immunotherapy
Oliver Pfaar1, Eckard Hamelmann2, Christian Taube3, Martin Wagenmann4, Bettina Wedi5, Thomas Werfel6, Detlef Bartel7, Andreas Bonertz7, Diana Hartenstein7, Susanne Kaul7, Vera Mahler7, Margitta Worm8
1 Section of Rhinology and Allergy, Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Marburg, Philipps-Universität Marburg, Marburg, 2 Children’s Center Bethel, University Hospital OWL, Bielefeld University, Bielefeld, 3 Department of Pulmonary Medicine, University Hospital Essen – Ruhrlandklinik, Essen, 4 Department of Otorhinolaryngology, Düsseldorf University Hospital, Heinrich Heine University, Düsseldorf, 5 Comprehensive Allergy Center, Department of Dermatology and Allergy, Hannover Medical School, Hannover, 6 Department of Dermatology and Allergy, Hannover Medical School, Hannover, 7 Paul-Ehrlich-Institut, Langen, 8 Allergology and Immunology, Department of Dermatology, Venereology and Allergology, Charité-Universitätsmedizin Berlin, Berlin, Germany

Add to Cart  

 

DOI 10.5414/ALX02450E

Abstract

A roundtable discussion on February 10, 2023 between the German Society for Allergology and Clinical Immunology (DGAKI) and the Paul-Ehrlich-Institut (PEI) aimed to discuss in detail current aspects of allergen immunotherapy (AIT), its regulatory framework under the transitional provision of the Therapy Allergen Ordinance (TAO), and the consequences for the planned guideline work of the DGAKI, regulatory challenges in the approval of AIT products for children and adolescents as well as allergy diagnostics. The content and discussion points of this dialogue are summarized and are set in context with the current literature.

Author Details

Authors

Departments

  • 1 Section of Rhinology and Allergy, Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Marburg, Philipps-Universität Marburg, Marburg,
  • 2 Children’s Center Bethel, University Hospital OWL, Bielefeld University, Bielefeld,
  • 3 Department of Pulmonary Medicine, University Hospital Essen – Ruhrlandklinik, Essen,
  • 4 Department of Otorhinolaryngology, Düsseldorf University Hospital, Heinrich Heine University, Düsseldorf,
  • 5 Comprehensive Allergy Center, Department of Dermatology and Allergy, Hannover Medical School, Hannover,
  • 6 Department of Dermatology and Allergy, Hannover Medical School, Hannover,
  • 7 Paul-Ehrlich-Institut, Langen,
  • 8 Allergology and Immunology, Department of Dermatology, Venereology and Allergology, Charité-Universitätsmedizin Berlin, Berlin, Germany

Address

Prof. Dr. med. Oliver Pfaar, Section of Rhinology and Allergy, Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Marburg, Philipps-Universität, Marburg, Baldinger Strasse, 35043 Marburg, Germany
Email: [email protected]

Citation

Oliver Pfaar, Eckard Hamelmann, Christian Taube, Martin Wagenmann, Bettina Wedi, Thomas Werfel, Detlef Bartel, Andreas Bonertz, Diana Hartenstein, Susanne Kaul, Vera Mahler, and Margitta Worm.DGAKI and PEI in dialogue 2023: Diagnostics and allergen immunotherapy. Allergologie Select. 2023; 7: 229-235. doi: 10.5414/ALX02450E.

###article_not_exists_msg###

Warenkorb Übersicht

Warenkorb Übersicht
Typ Anz Rabatt MwSt Preis
Der Warenkorb ist leer
Ihr Warenkorb